ACLS Provider: Course

Incorrect. Oxygen levels should be monitored and optimized to maintain saturation within the target range of 92-96%.

Incorrect. For biphasic defibrillators, 120-200 J is the recommended energy range for VF.

Incorrect. PETCO2 readings above 10 mmHg during CPR indicate adequate chest compressions and cardiac output.

Incorrect. Epinephrine at 0.01 mg/kg IV/IO is administered every 3-5 minutes to enhance coronary and cerebral perfusion in children.

Incorrect. Magnesium sulfate stabilizes the cardiac membrane and is the drug of choice for treating torsades de pointes.

Incorrect. Reduces the risk of oxidative stress and worsened outcomes by preventing hyperoxia.

Incorrect. The correct compression-to-ventilation ratio for adult CPR without an advanced airway is 30:2.

Incorrect. Pulseless VT is treated with defibrillation, not atropine. Atropine is used for symptomatic bradycardia.

Incorrect. VF is a shockable rhythm that requires immediate defibrillation to restore organized cardiac activity.

Incorrect. Maintaining a compression fraction of greater than 80% ensures the majority of resuscitation time is spent on compressions.

Incorrect. CPR is the primary intervention for PEA, followed by epinephrine and identification of reversible causes.

Incorrect. Epinephrine 1 mg IV/IO is administered every 3-5 minutes during cardiac arrest to improve coronary and cerebral perfusion.

Incorrect. Vagal maneuvers stimulate the vagus nerve, often terminating narrow-complex SVT caused by reentrant circuits.

Incorrect. Biphasic defibrillators deliver effective shocks within the range of 120-200 J to treat VF or pulseless VT.

Incorrect. Magnesium sulfate stabilizes the myocardium and is the drug of choice for torsades de pointes.

Incorrect. Maintaining oxygen saturation at 92-96% prevents hypoxia and avoids complications associated with hyperoxia.

Incorrect. A 15:2 ratio ensures efficient oxygenation and circulation in pediatric patients during two-rescuer CPR.

Incorrect. Magnesium sulfate stabilizes cardiac myocytes and is the drug of choice for treating torsades de pointes.

Incorrect. Atropine is given at a dose of 0.5 mg every 3-5 minutes during bradycardia, up to a maximum dose of 3 mg.

Incorrect. Atrial fibrillation is cardioverted starting at 120-200 J in synchronized mode to avoid delivering the shock during ventricular repolarization.

Incorrect. Adenosine 6 mg is given as a rapid IV push for terminating narrow-complex SVT caused by reentrant pathways.

Incorrect. Delivering 6-8 breaths per minute ensures adequate oxygenation without hyperventilation during CPR with an advanced airway.

Incorrect. Hypoxia is the most frequent reversible cause of PEA and should be addressed immediately with oxygenation and ventilation.

Incorrect. Adenosine is administered as a rapid IV push to terminate SVT in pediatric patients, followed by a saline flush.

Incorrect. Needle decompression relieves pressure caused by tension pneumothorax, improving ventilation and circulation.

Incorrect. Epinephrine is administered after defibrillation to enhance coronary and cerebral perfusion during resuscitation.

Incorrect. Switching every 2 minutes reduces rescuer fatigue and ensures high-quality chest compressions.

Incorrect. Synchronized cardioversion is used to restore a normal rhythm in unstable atrial fibrillation.

Incorrect. PETCO2 values greater than 10 mmHg during CPR indicate adequate chest compressions and blood circulation.

Incorrect. The compression fraction should be greater than 80% to maximize perfusion during CPR.

Incorrect. Synchronized cardioversion with 120-200 J is used to restore normal rhythm in unstable atrial fibrillation.

Incorrect. Pulse checks should be limited to 5-10 seconds to minimize interruptions in chest compressions.

Incorrect. Minimizes interruptions to maintain blood flow to vital organs.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and is treated by warming the patient to improve outcomes.

Incorrect. VF is a shockable rhythm, and immediate defibrillation is the most effective treatment.

Incorrect. Hypothermia is a potentially reversible cause of cardiac arrest and should be addressed during resuscitation.

Incorrect. High-quality CPR is the primary intervention for PEA, followed by epinephrine administration and addressing reversible causes.

Incorrect. IO access provides a reliable alternative for rapid drug delivery during resuscitation when IV access cannot be obtained.

Incorrect. Post-ROSC care focuses on stabilizing ventilation and oxygenation to prevent hypoxia or hyperoxia.

Incorrect. Hypoxia is a reversible cause of PEA; it must be treated immediately with oxygenation and ventilation.

Incorrect. Delivers an electrical shock to depolarize the heart and restore a normal rhythm.

Incorrect. Naloxone is only used in cases of suspected opioid overdose and is not universally administered in cardiac arrest.

Incorrect. Epinephrine at 1 mg IV every 3-5 minutes is used to enhance perfusion during cardiac arrest.

Incorrect. Magnesium sulfate is used to treat torsades de pointes but is not the first-line drug for VF, where epinephrine is prioritized.

Incorrect. Amiodarone is administered as a 300 mg IV/IO bolus for refractory VF or pulseless VT.

Incorrect. TTM helps reduce neurological injury after ROSC by maintaining a target temperature between 32-36°C.

Incorrect. Biphasic defibrillators deliver effective shocks within the range of 120-200 J, restoring organized electrical activity.

Incorrect. Post-ROSC care focuses on optimizing oxygenation, ventilation, and hemodynamic stability to prevent further organ damage.

Incorrect. IM epinephrine is the first-line treatment for anaphylaxis, administered into the mid-thigh for rapid absorption.

Incorrect. Epinephrine at 0.01 mg/kg is administered every 3-5 minutes during pediatric cardiac arrest to improve coronary perfusion.

Incorrect. The recommended rate for chest compressions is 100-120 compressions per minute to maximize perfusion.

Incorrect. Atropine at 0.5 mg IV is the first-line treatment for symptomatic bradycardia caused by vagal stimulation.

Incorrect. The correct compression rate for CPR is 100-120 compressions per minute to optimize perfusion and prevent fatigue.

Incorrect. For adult CPR, the ratio ensures adequate perfusion and oxygenation when no advanced airway is in place.

Incorrect. VF is a shockable rhythm, and defibrillation is the primary treatment to restore an organized rhythm.

Incorrect. The jaw thrust maneuver opens the airway without manipulating the cervical spine, protecting against spinal cord injury.

Incorrect. Adequate oxygenation and ventilation are critical to preventing hypoxia or hyperoxia after ROSC.

Incorrect. Asystole is not a shockable rhythm; it is treated with high-quality CPR and epinephrine.

Incorrect. Vagal maneuvers stimulate the vagus nerve, often terminating reentrant arrhythmias causing narrow-complex tachycardia.

Incorrect. CPR is the primary treatment for PEA, along with epinephrine and addressing reversible causes to restore circulation.

Incorrect. ROSC stands for "Return of Spontaneous Circulation," indicating the resumption of a perfusing rhythm.

Incorrect. Hypovolemia is a reversible cause of PEA and can be treated with rapid fluid resuscitation.

Incorrect. PETCO2 levels greater than 10 mmHg suggest that chest compressions are generating adequate circulation.

Incorrect. The compression-to-ventilation ratio for single-rescuer infant CPR is 30:2, ensuring sufficient oxygenation and circulation.

Incorrect. Dopamine is used to improve heart rate and contractility in bradycardia unresponsive to atropine.